Oncolytics Biotech
ONCY
#9651
Rank
ยฃ73.86 M
Marketcap
ยฃ0.62
Share price
-3.60%
Change (1 day)
-32.22%
Change (1 year)

Oncolytics Biotech (ONCY) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ9.93 Million

According to Oncolytics Biotech 's latest financial reports the company's total liabilities are ยฃ9.93 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oncolytics Biotech - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ8.45 M4.76%
2024-12-31ยฃ8.06 M21.11%
2023-12-31ยฃ6.66 M0.96%
2022-12-31ยฃ6.59 M16.08%
2021-12-31ยฃ5.68 M2.97%
2020-12-31ยฃ5.51 M-52.17%
2019-12-31ยฃ11.53 M130.11%
2018-12-31ยฃ5.01 M-13.62%
2017-12-31ยฃ5.8 M136.65%
2016-12-31ยฃ2.45 M86.19%
2015-12-31ยฃ1.31 M-29.42%
2014-12-31ยฃ1.86 M-45.43%
2013-12-31ยฃ3.42 M-24.56%
2012-12-31ยฃ4.53 M10.64%
2011-12-31ยฃ4.09 M153.06%
2010-12-31ยฃ1.61 M-35.07%
2009-12-31ยฃ2.49 M-1.87%
2008-12-31ยฃ2.54 M77.27%
2007-12-31ยฃ1.43 M18.35%
2006-12-31ยฃ1.21 M31.71%
2005-12-31ยฃ0.91 M93.14%
2004-12-31ยฃ0.47 M6.76%
2003-12-31ยฃ0.44 M-20.14%
2002-12-31ยฃ0.55 M-58.65%
2001-12-31ยฃ1.35 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
ยฃ63.84 B 642,274.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ49.63 B 499,290.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
ยฃ0.13 B 1,278.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
ยฃ17.81 M 79.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ23.78 B 239,219.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
ยฃ54.13 M 444.64%๐Ÿ‡บ๐Ÿ‡ธ USA